Bugatone

Company Overview

Snapshot

Founded in February 2013 by Edmund Ben Ami and Noam Petrank, Bugatone operates with 1–10 employees. The company has raised $5.5M across 3 funding rounds from 4 investors. In December 2017, Bugatone received an investment from Oppo and Wellborn Ventures.

Business overview

Bugatone develops software that enhances earphone capabilities, focusing on improving audio quality through active noise cancellation and measuring users' vital signs. The company's technology functions like a sonar device, emitting imperceptible sound waves into the ear canal and interpreting the returning signals. Bugatone operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring, targeting consumers with its software applications.

Strategic signal

In December 2017, Bugatone secured an investment from Oppo, a significant player in consumer electronics. This investment signals a strategic validation of Bugatone's earphone-enhancing software and its potential applications in the broader consumer market, particularly for integrating advanced audio and biometric functionalities into mainstream devices.

Company Intelligence Q&A

What is Bugatone's primary business?

Bugatone develops software that enhances earphone capabilities, including active noise cancellation and vital sign measurement, using sonar-like technology.

When was Bugatone founded?

Bugatone was founded in February 2013 by Edmund Ben Ami and Noam Petrank.

What was a significant funding event for Bugatone?

In December 2017, Bugatone received an investment from Oppo and Wellborn Ventures.

What is Bugatone's operational status?

Bugatone is currently non-active, having ceased operations in February 2021.

Which investors participated in Bugatone's June 2015 funding round?

In June 2015, Bugatone received funding from Wellborn Ventures, Maya Liquornik, and Alon Sahar.